The US Food and Drug Administration (FDA) has approved Multi Radiance Medical’s (MRM) FibroLux laser therapy to treat pain related to fibromyalgia.
The new patent-pending therapy uses a photoceutical approach to provide a non-pharmacological, non-invasive and side-effect-free treatment for fibromyalgia patients.
It represents a breakthrough in pain management options for fibromyalgia, which is defined as chronic widespread pain and tenderness in specific tender points by the American College of Rheumatology.
